-
Mashup Score: 0Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis - 8 month(s) ago
Advances in the genomic era have led to identification of cancer-causing genes and unprecedented progress in the development of gene-targeted therapies and agents that can unleash the immune system. These advances have improved the outlook for patients with lethal malignancies. Cancer is a genomic disease in that gene alterations drive the cellular growth and immune surveillance perturbations that enable malignant cells to take hold and to metastasize. Hereditary genetic factors play a key role in cancer
Source: ascopubs.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis - 8 month(s) ago
Advances in the genomic era have led to identification of cancer-causing genes and unprecedented progress in the development of gene-targeted therapies and agents that can unleash the immune system. These advances have improved the outlook for patients with lethal malignancies. Cancer is a genomic disease in that gene alterations drive the cellular growth and immune surveillance perturbations that enable malignant cells to take hold and to metastasize. Hereditary genetic factors play a key role in cancer
Source: ascopubs.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
This cohort study assesses which patients with advanced solid tumors derive the greatest clinical benefit from next-generation sequencing.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines - 10 month(s) ago
This cross-sectional study examines the prevalence of germline findings in patients undergoing tumor/normal matched sequencing among cancer types lacking guidelines.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 10 month(s) ago
AuthorsDavid HeinUT Southwestern Medical Center, Dallas, TXDavid Hein, Brooke Rhead, Yannick Pouliot, Justin Guinney, Francisco M De La Vega, Nina Niu SanfordOrganizationsUT Southwestern Medical Center, Dallas, TX, Tempus, Chicago, IL, Tempus Labs, Inc., Chicago, ILAbstract DisclosuresResearch FundingOther FoundationDedman Family Scholarship Background: There is a growing incidence of…
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 11 month(s) ago
AuthorsRamaswamy GovindanWashington University School of Medicine, St. Louis, MORamaswamy Govindan, Katie Navo, Minxuan Huang, Calvin Y. Chao, Sumithra Sankararaman, KELLY L BOLTON, Yin CaoOrganizationsWashington University School of Medicine, St. Louis, MO, Tempus Labs, Inc., Chicago, IL, Washington University in Saint Louis, St. Louis, MOAbstract DisclosuresResearch FundingOtherTempus …
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines - 11 month(s) ago
This cross-sectional study examines the prevalence of germline findings in patients undergoing tumor/normal matched sequencing among cancer types lacking guidelines.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 11 month(s) ago
ASCO-SEP 2022 Digital SubscriptionA comprehensive program for your self-assessment needs includes all-digital SEP® content (22 chapters + more chapter questions), an updated Question Bank, and additional educational resources. Subscribe today!
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing Guidelines - 11 month(s) ago
This cross-sectional study examines the prevalence of germline findings in patients undergoing tumor/normal matched sequencing among cancer types lacking guidelines.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Program Guide – ASCO Meeting Program Guide - 1 year(s) ago
AuthorsDavid HeinUT Southwestern Medical CenterDavid Hein, Brooke Rhead, Yannick Pouliot, Justin Guinney, Francisco De La Vega, Nina SanfordOrganizationsUT Southwestern Medical Center, Tempus, Tempus Labs, Inc.Abstract Disclosures This material on this page is ©2023 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact…
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis [Mar 17, 2023] @VivekSubbiah @Dr_R_Kurzrock @JCO_ASCO https://t.co/Os4PdAxBvW #PrecisionMedicine #cagenome #GeneticCounselors